This content is machine translated COPD and emphysema therapy What can the family doctor do and when does the patient need to see a pulmonologist? At the Update Refresher, one presentation was dedicated to COPD and emphysema. It was shown which questions should already be clarified in the family practice and how the patient can…
View Post 3 min This content is machine translated New guidelines for acute pulmonary embolism Close monitoring in patients at intermediate risk of mortality. The ESC issued new recommendations on the diagnosis and management of acute pulmonary embolism toward the end of last year [1]. The most relevant innovations compared with the 2008 version…
View Post 2 min This content is machine translated Non-small cell lung cancer CheckMate 057 with promising results Patients with advanced non-squamous type non-small cell lung cancer (NSCLC) benefit from nivolumab after failed platinum-containing chemotherapy. This is the conclusion of the CheckMate 057 study. The tested substance was…
View Post 2 min This content is machine translated Lung cancer Living longer thanks to cancer? A current forecast [1] for the year 2015, which is based on statistics from the WHO and data from individual European countries, indicates that theThe picture regarding lung cancer is…
View Post 4 min This content is machine translated Onco-training in St. Gallen Targeted systems therapy in metastatic NSCLC. In more than half of all patients with lung cancer, metastases are already present at the time of diagnosis. In recent years, new compounds have been developed that can be…
View Post 12 min This content is machine translated Non-necrotizing granulomas Diagnosis and therapy of sarcoidosis Sarcoidosis is a multisystemic granulomatous disease of as yet unclear etiology. The diagnosis of sarcoidosis is based on the typical clinical presentation and histologic evidence of non-necrotizing epithelioid cell granulomas,…
View Post 7 min This content is machine translated Pulmonary emphysema When is interventional therapy indicated? Often, even “out of treatment” emphysema patients can be offered improvement in dyspnea and exercise capacity through a lung volume reducing procedure. The postinterventional beneficial effects after surgical or bronchoscopic…
View Post 6 min This content is machine translated 19th Zurich Cardiovascular Day Putting patients through their paces The Cardiovascular Day at the Marriott Hotel in Zurich provided a broad overview of the three most important organs in the circulatory system: heart, kidney and brain. In addition to…
View Post 6 min This content is machine translated Not always bronchitis or asthma Cough in a child – how to clarify and treat? Cough in a child usually has a harmless cause, but can be very stressful for the patient and the whole family. If the cough occurs as the sole symptom, asthma…
View Post 7 min This content is machine translated Surgical therapy for lung cancer Staging, operability, and prognostic factors determine the indication The choice of therapeutic modalities for lung cancer depends on several factors. Accurate staging, assessment of operability, and knowledge of prognostic factors such as the number of affected lymph node…
View Post 5 min This content is machine translated Addiction Medicine Many addicts suffer from lung and liver diseases At the Swiss Family Docs Congress, André Seidenberg, MD, Zurich, and Philip Bruggmann, MD, Zurich, presented a workshop on addiction medicine. The focus was not on addiction per se, but…
